Literature DB >> 7107894

Energy metabolism of human neutrophils during phagocytosis.

N Borregaard, T Herlin.   

Abstract

Detailed quantitative studies were performed on the generation and utilization of energy by resting and phagocytosing human neutrophils. The ATP content was 1.9 fmol/cell, was constant during rest, and was not influenced by the presence or absence of glucose in the medium. The intracellular content of phosphocreatine was less than 0.2 fmol/cell. In the presence of glucose, ATP was generated almost exclusively from lactate produced from glucose taken up from the surrounding medium. The amount of lactate produced could account for 85% of the glucose taken up by the cells, and the intracellular glycosyl store, glycogen, was not drawn upon. The rate of ATP generation as calculated from the rate of lactate production was 1.3 fmol/cell/min. During phagocytosis, there was no measurable increase in glucose consumption or lactate production, and the ATP content fell rapidly to 0.8 fmol/cell. This disappearance of ATP was apparently irreversible since no corresponding increase in ADP or AMP was observed. It therefore appears that this phagocytosis-induced fall in ATP concentration represents all the extra energy utilized in human neutrophils in the presence of glucose. In the absence of glucose, the rate of ATP generation in the resting cell was considerably smaller, 0.75 fmol/cell per min, as calculated from the rate of glycolysis, which is sustained exclusively by glycogenolysis. Under this condition, however, phagocytosis induces significant enhancement of glycogenolysis and the rate of lactate production is increased by 60%, raising the rate of ATP generation to 1.2 fmol/cell per min. Nonetheless, the ATP content drops significantly from 1.9 to 1.0 fmol/cell. Neutrophils from patients with chronic granulomatous disease have the same rate of glycolysis and the same ATP content as normal cells, thus confirming that the defective respiration of these cells does not affect their energy metabolism.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7107894      PMCID: PMC370256          DOI: 10.1172/jci110647

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  28 in total

1.  The energy metabolism of human-blood polymorphonuclear cells. Action of various effectors, except hormones.

Authors:  J C Marchand; J P Leroux; P Cartier
Journal:  Eur J Biochem       Date:  1972-12-18

2.  Regulation of glycogen metabolism in polymorphonuclear leukocytes.

Authors:  T P Stossel; F Murad; R J Mason; M Vaughan
Journal:  J Biol Chem       Date:  1970-11-25       Impact factor: 5.157

Review 3.  The diabetic leukocyte.

Authors:  V Esmann
Journal:  Enzyme       Date:  1972

4.  Metabolic control and intracellular pH during phagocytosis by polymorphonuclear leucocytes.

Authors:  K Kakinuma
Journal:  J Biochem       Date:  1970-08       Impact factor: 3.387

5.  A modified flow microcalorimeter adapted for the study of human leucocyte phagocytosis.

Authors:  K Levin
Journal:  Scand J Clin Lab Invest       Date:  1973-08       Impact factor: 1.713

6.  A new assay of phosphorylase based on the filter paper technique.

Authors:  P Wang; V Esmann
Journal:  Anal Biochem       Date:  1972-06       Impact factor: 3.365

7.  Carbohydrate metabolism in leukocytes. XIV. Regulation of pentose cycle activity and glycogen metabolism during phagocytosis.

Authors:  R L Stjernholm; R C Manak
Journal:  J Reticuloendothel Soc       Date:  1970-12

8.  Phagocytosis-associated metabolism and enzymes in the rat polymorphonuclear leukocyte.

Authors:  P W Reed; J Tepperman
Journal:  Am J Physiol       Date:  1969-02

9.  Studies of the metabolic activity of leukocytes from patients with a genetic abnormality of phagocytic function.

Authors:  B Holmes; A R Page; R A Good
Journal:  J Clin Invest       Date:  1967-09       Impact factor: 14.808

10.  The pentose cycle and insulin release in mouse pancreatic islets.

Authors:  S J Ashcroft; L C Weerasinghe; J M Bassett; P J Randle
Journal:  Biochem J       Date:  1972-02       Impact factor: 3.857

View more
  180 in total

1.  HIF-1alpha is essential for myeloid cell-mediated inflammation.

Authors:  Thorsten Cramer; Yuji Yamanishi; Björn E Clausen; Irmgard Förster; Rafal Pawlinski; Nigel Mackman; Volker H Haase; Rudolf Jaenisch; Maripat Corr; Victor Nizet; Gary S Firestein; Hans Peter Gerber; Napoleone Ferrara; Randall S Johnson
Journal:  Cell       Date:  2003-03-07       Impact factor: 41.582

Review 2.  Peculiarities of cell death mechanisms in neutrophils.

Authors:  B Geering; H-U Simon
Journal:  Cell Death Differ       Date:  2011-06-03       Impact factor: 15.828

Review 3.  Adenosine and hypoxia-inducible factor signaling in intestinal injury and recovery.

Authors:  Sean P Colgan; Holger K Eltzschig
Journal:  Annu Rev Physiol       Date:  2011-11-19       Impact factor: 19.318

4.  Changing the energy of an immune response.

Authors:  Meghan M Delmastro-Greenwood; Jon D Piganelli
Journal:  Am J Clin Exp Immunol       Date:  2013-02-27

Review 5.  Immunometabolism: Cellular Metabolism Turns Immune Regulator.

Authors:  Róisín M Loftus; David K Finlay
Journal:  J Biol Chem       Date:  2015-11-03       Impact factor: 5.157

Review 6.  Metabolic abnormalities and oxidative stress in lupus.

Authors:  Yaima L Lightfoot; Luz P Blanco; Mariana J Kaplan
Journal:  Curr Opin Rheumatol       Date:  2017-09       Impact factor: 5.006

7.  Extensive FDG uptake and its modification with corticosteroid in a granuloma rat model: an experimental study for differentiating granuloma from tumors.

Authors:  Songji Zhao; Yuji Kuge; Masashi Kohanawa; Toshiyuki Takahashi; Hidekazu Kawashima; Takashi Temma; Toshiki Takei; Yan Zhao; Koh-ichi Seki; Nagara Tamaki
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-09-01       Impact factor: 9.236

8.  Treating neutropenia and neutrophil dysfunction in glycogen storage disease type Ib with an SGLT2 inhibitor.

Authors:  Saskia B Wortmann; Johan L K Van Hove; Terry G J Derks; Nathalie Chevalier; Vijaya Knight; Andreas Koller; Esmee Oussoren; Johannes A Mayr; Francjan J van Spronsen; Florian B Lagler; Sommer Gaughan; Emile Van Schaftingen; Maria Veiga-da-Cunha
Journal:  Blood       Date:  2020-08-27       Impact factor: 22.113

Review 9.  Genetic heterogeneity in severe congenital neutropenia: how many aberrant pathways can kill a neutrophil?

Authors:  Alejandro A Schäffer; Christoph Klein
Journal:  Curr Opin Allergy Clin Immunol       Date:  2007-12

10.  Mechanism of the salutary effects of estrogen on kupffer cell phagocytic capacity following trauma-hemorrhage: pivotal role of Akt activation.

Authors:  Chi-Hsun Hsieh; Eike A Nickel; Jianguo Chen; Martin G Schwacha; Mashkoor A Choudhry; Kirby I Bland; Irshad H Chaudry
Journal:  J Immunol       Date:  2009-04-01       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.